Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. doi: 10.1136/bjo.2007.135111. Epub 2008 Nov 19. Review.

2.

Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

Eisenberg DL, Toris CB, Camras CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S105-15. Review.

PMID:
12204706
3.

[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].

Vinuesa-Silva JM, Vinuesa-Silva I, Pinazo-Durán MD, Soto-Alvarez J, Delgado-Ortega L, Díaz-Cerezo S.

Arch Soc Esp Oftalmol. 2009 Apr;84(4):199-207. Review. Spanish.

5.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.

Curr Med Res Opin. 2007 Mar;23(3):601-8. Review.

PMID:
17355741
6.

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Easthope SE, Perry CM.

Drugs Aging. 2002;19(3):231-48. Review.

PMID:
12027782
7.

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension.

Orme M, Collins S, Dakin H, Kelly S, Loftus J.

Curr Med Res Opin. 2010 Mar;26(3):511-28. doi: 10.1185/03007990903498786. Review.

PMID:
20014995
8.

[Bimatoprost therapy in glaucoma].

Călugăru D, Călugăru M.

Oftalmologia. 2009;53(3):34-45. Review. Romanian.

PMID:
19899545
9.

Prostaglandin analog treatment of glaucoma and ocular hypertension.

Alexander CL, Miller SJ, Abel SR.

Ann Pharmacother. 2002 Mar;36(3):504-11. Review.

PMID:
11895065
10.

Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.

Fung AT, Reid SE, Jones MP, Healey PR, McCluskey PJ, Craig JC.

Br J Ophthalmol. 2007 Jan;91(1):62-8. Epub 2006 Sep 6. Review.

11.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
12.

[Monotherapy with lipid structural derivatives in glaucoma].

Călugăru D, Călugăru M.

Oftalmologia. 2010;54(2):30-43. Review. Romanian.

PMID:
20827909
13.

The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review.

Hodge WG, Lachaine J, Steffensen I, Murray C, Barnes D, Foerster V, Ducruet T, Morrison A.

Br J Ophthalmol. 2008 Jan;92(1):7-12. Review.

PMID:
18156371
14.

Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.

Plosker GL, Keam SJ.

Pharmacoeconomics. 2006;24(3):297-314. Review.

PMID:
16519552
15.

Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension.

Feldman RM.

J Ocul Pharmacol Ther. 2003 Feb;19(1):23-35. Review.

PMID:
12648301
16.
17.

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

Holmstrom S, Buchholz P, Walt J, Wickstrøm J, Aagren M.

Curr Med Res Opin. 2005 Nov;21(11):1875-83. Review.

PMID:
16307709
18.

Effects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y.

Curr Ther Res Clin Exp. 2009 Aug;70(4):335-50. doi: 10.1016/j.curtheres.2009.08.006. Review.

19.

Latanoprost in the treatment of glaucoma.

Alm A.

Clin Ophthalmol. 2014 Sep 26;8:1967-85. doi: 10.2147/OPTH.S59162. eCollection 2014. Review.

20.

Sustained drug delivery for glaucoma: current data and future trends.

Aref AA.

Curr Opin Ophthalmol. 2017 Mar;28(2):169-174. doi: 10.1097/ICU.0000000000000334. Review.

PMID:
27764023

Supplemental Content

Support Center